Antiproliferative and receptor binding properties of - and -casomorphins in the T47D human breast cancer cell line

By Hatzoglou A.   Bakogeorgou E.   Hatzoglou C.   Martin P.-M.   Castanas E.  

European Journal of Pharmacology, Vol. 310, Iss. 2, 1996-08 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Relative efficacies of -opioid receptor agonists at the cloned human -opioid receptor

By Quock R.M.   Hosohata Y.   Knapp R.J.   Burkey T.H.   Hosohata K.   Zhang X.   Rice K.C.   Nagase H.   Hruby V.J.   Porreca F.   Roeske W.R.   Yamamura H.I.  

European Journal of Pharmacology, Vol. 326, Iss. 1, 1997-05 ,pp. : 101-104

Elsevier

Access to resources Recommend Favorite

Differential desensitization of human -opioid receptors by peptide and alkaloid agonists

By Allouche S.   Roussel M.   Marie N.   Jauzac P.  

European Journal of Pharmacology, Vol. 371, Iss. 2, 1999-04 ,pp. : 235-240

Elsevier

Access to resources Recommend Favorite

Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned - or -opioid receptors

By Nakagawa T.   Minami M.   Satoh M.  

European Journal of Pharmacology, Vol. 433, Iss. 1, 2001-12 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

Antiparkinson potential of -opioid receptor agonists

By Hudzik T.J.   Howell A.   Payza K.   Cross A.J.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite